A41 Stock Chart & Stats
€101.00
€1.00(1.05%)
At close: 4:00 PM EDT
€101.00
€1.00(1.05%)
Day’s Range― - ―
52-Week Range€74.50 - €104.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.93B
Enterprise Value€1.87B
Total Cash (Recent Filing)€99.57M
Total Debt (Recent Filing)€108.82M
Price to Earnings (P/E)20.4
Beta0.13
Next Earnings
Nov 03, 2026EPS Estimate
1.59Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.68
Shares Outstanding18,674,300
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.04
Price to Book (P/B)1.83
Price to Sales (P/S)1.39
P/FCF Ratio19.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€111.42Price Target Upside10.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)6.27
Revenue Forecast (FY)€1.36B
Bulls Say, Bears Say
Bulls Say
Scaled Personal Care ExpansionThe AccentCare transaction would materially expand Addus’s personal care scale, geographic reach, and customer base. Greater density across major states can strengthen payer relationships, broaden operating capabilities, and support durable revenue growth once regulatory approvals and closing conditions are completed.
Organic Revenue GrowthGrowth across the core Personal Care business and Hospice segment indicates demand is extending beyond acquisition-led expansion. Rising same-store revenue and hospice census provide a stronger foundation for recurring growth and should support operating leverage as the platform scales.
Low Leverage And Strong Cash GenerationThe sharply reduced debt burden lowers financial risk and interest pressure while preserving flexibility for acquisitions and investment. Strong operating and free cash flow also demonstrate meaningful cash conversion, giving Addus internal funding capacity to sustain expansion and absorb volatility.
Bears Say
Caregiver Capacity Constrains GrowthCaregiver availability directly limits Addus’s ability to convert patient demand into authorized, billable service hours. Persistent recruitment and retention pressure can cap organic growth and require higher labor spending, reducing the benefit of favorable demand and reimbursement conditions.
Home Health Remains In DeclineThe continuing year-over-year decline makes Home Health a drag on consolidated growth and leaves the segment needing further operational recovery. Sequential improvement is encouraging, but the business has not yet returned to positive same-store revenue growth, limiting near-term mix benefits.
Leadership Transition RiskA senior operating leadership change introduces execution risk while Addus is integrating acquisitions and pursuing further expansion. An experienced interim appointment provides continuity, but the temporary structure may still create uncertainty around long-term accountability and strategic implementation.
A41 FAQ
What was Addus Homecare’s price range in the past 12 months?
Addus Homecare lowest stock price was €74.50 and its highest was €104.00 in the past 12 months.
What is Addus Homecare’s market cap?
Addus Homecare’s market cap is €1.93B.
When is Addus Homecare’s upcoming earnings report date?
Addus Homecare’s upcoming earnings report date is Nov 03, 2026 which is in 14 days.
How were Addus Homecare’s earnings last quarter?
Addus Homecare released its earnings results on Aug 03, 2026. The company reported €1.541 earnings per share for the quarter, beating the consensus estimate of €1.512 by €0.028.
Is Addus Homecare overvalued?
According to Wall Street analysts Addus Homecare’s price is currently Undervalued.
Does Addus Homecare pay dividends?
Addus Homecare does not currently pay dividends.
What is Addus Homecare’s EPS estimate?
Addus Homecare’s EPS estimate is 1.59.
How many shares outstanding does Addus Homecare have?
Addus Homecare has 18,674,300 shares outstanding.
What happened to Addus Homecare’s price movement after its last earnings report?
Addus Homecare reported an EPS of €1.541 in its last earnings report, beating expectations of €1.512. Following the earnings report the stock price went up 1.523%.
Which hedge fund is a major shareholder of Addus Homecare?
Currently, no hedge funds are holding shares in DE:A41
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Addus Homecare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€111.42 (10.32% Upside)
€111.42 (10.32% Upside)
Blogger Sentiment
Bullish
DE:A41 Sentiment 83%
Sector Average 66%
Sector Average 66%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.98%
12-Months-Change
Fundamentals
Return on Equity
9.57%
Trailing 12-Months
Asset Growth
3.38%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Addus Homecare
Addus HomeCare Corporation, through its various subsidiaries, offers essential personal support services across the United States. The company primarily assists seniors, individuals with chronic illnesses or disabilities, and those at risk of hospitalization or institutionalization. Its operations are structured into three primary segments: Personal Care, Hospice, and Home Health. The Personal Care division delivers non-medical assistance with daily living activities, including help with personal hygiene (bathing, grooming, oral care), eating, dressing, medication reminders, meal preparation, household chores, and transportation. Through its Hospice segment, Addus provides compassionate palliative nursing care, social work, spiritual guidance, homemaker services, and bereavement support to terminally ill individuals and their families. The Home Health segment delivers professional skilled nursing care alongside physical, occupational, and speech therapy for patients recovering from illness or following a hospital discharge. Addus HomeCare's diverse client base includes federal, state, and local government entities, managed care organizations, commercial insurance providers, and private-paying individuals. As of December 31, 2021, the company served consumers through a network of 206 offices located across 22 states. Established in 1979, Addus HomeCare Corporation is headquartered in Frisco, Texas.
A41 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was broadly positive, characterized by strong revenue, earnings, EBITDA, cash flow and debt-reduction performance; growth in Personal Care and hospice; improving home health trends; successful early performance from the Indiana acquisition; and an expanding acquisition pipeline. The main challenges were the Medicare Cap accrual, the year-over-year home health revenue decline, muted Texas census growth, slower New Mexico app adoption, the proposed home health temporary adjustment, a higher tax rate and the likelihood that cash flow benefits will moderate. Highlights significantly outweighed lowlights.View all DE:A41 earnings summariesA41 Stock 12 Month Forecast
Average Price Target
€111.42
▲(10.32% Upside)
Technical Analysis
National Healthcare
―
―
US Physical Therapy
―
Pennant Group
―
Aveanna Healthcare Holdings
―








